Probable risk of tumour induction after retro-orbital irradiation for Graves' ophthalmopathy
- 1 January 1996
- journal article
- case report
- Published by Elsevier in Radiotherapy and Oncology
- Vol. 38 (1) , 69-71
- https://doi.org/10.1016/0167-8140(95)01670-8
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Therapeutic controversies. Retro-orbital radiation and radioactive iodide ablation of the thyroid may be good for Graves' ophthalmopathy [published erratum appears in J Clin Endocrinol Metab 1995 Jul;80(7):2117]Journal of Clinical Endocrinology & Metabolism, 1995
- Second cancer risk following Hodgkin's disease: a 20-year follow-up study.Journal of Clinical Oncology, 1994
- Randomised double-blind trial of prednisone versus radiotherapy in Graves' ophthalmopathyThe Lancet, 1993
- Risk of second brain tumour after conservative surgery and radiotherapy for pituitary adenoma.BMJ, 1992
- Radiation Retinopathy After Standard Radiotherapy for Thyroid-Related OphthalmopathyAmerican Journal of Ophthalmology, 1991
- Relative Biological Effectiveness for Neutron Carcinogenesis in Monkeys and RatsRadiation Research, 1991
- Prognostic factors in the radiotherapy of graves' ophthalmopathyInternational Journal of Radiation Oncology*Biology*Physics, 1990
- Orbital Decompression for Graves' Ophthalmopathy by Inferomedial, by Inferomedial Plus Lateral, and by Coronal ApproachOphthalmology, 1990